Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Endothelin Antagonist Trial in Mildly Symptomatic Pulmonary Arterial Hypertension: The EARLY Study
Link ID 7334
Title Endothelin Antagonist Trial in Mildly Symptomatic Pulmonary Arterial Hypertension: The EARLY Study
Url http://www.medscape.com/viewarticle/577964?src=rss
Description The EARLY study is the first randomized, double-blind, multicenter, placebo-controlled clinical trial to study the role of endothelin receptor antagonism on disease progression in early-stage PAH.
Medscape Pulmonary Medicine
Category Articles > Critical Care
Keywords
Date Aug 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Critical Care
1. Back Pain in a 39-Year-Old Man from Guatemala
  A 39-year-old Guatemalan man presents to the ED with severe and debilitating back pain. He has been previously evaluated for his back pain twice in the past few weeks. The pain is throbbing and diffuse throughout the lower back, with radiation to his left buttock and upper back, and it has been progressively worsening. Mild tenderness to palpation is noted in the midline lower back. A lumbar radiograph and a magnetic resonance imaging scan of the spine are obtained. What is the diagnosis? eMedicine Case Presentations
Category:   Articles > Critical Care


2. Intensifying Dialysis of No Benefit to Critically Ill Patients With Acute Kidney Injury
  Intensifying renal support beyond conventional levels does not improve survival in critically ill patients with acute kidney injury, according to findings from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial. Reuters Health Information
Category:   Articles > Critical Care


3. Cases from AHRQ WebM&M: What Was in Those Platelets?
  Bacterial contamination has become the leading transfusion-transmitted infectious risk. Can you detect it? Agency for Healthcare Research and Quality (AHRQ)
Category:   Articles > Critical Care


4. Lapatinib Not Cost Effective, Editorialists Argue
  Ringing in at roughly US$2900 a month, experts are questioning whether a new treatment schedule or other strategies can be used to make the drug more accessible. Medscape Medical News
Category:   Articles > Critical Care


5. Percutaneous Coronary Interventions and Statins Therapy
  A review of the evidence strongly supports routine utilization of statins as adjuvant pharmacological therapy before percutaneous coronary revascularization.
Therapeutic Advances in Cardiovascular Disease
Category:   Articles > Critical Care




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS